Rechercher

Pages

1. • Communication

   • 

   Invited lecture: Boosting cancer immunotherapy by blocking tryptophan degradation

   Van den Eynde, Benoît[UCL] (2012) 7th Annual HBGP Symposium, "Immunity and Inflammation in Disease" — Helsinki, Finland
2. • Article de périodique

   • 

   Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes

   Vigneron, Nathalie[UCL] Van den Eynde, Benoît[UCL] (2011) Cellular and Molecular Life Sciences — Vol. 68, no. 9, p. 1503-1520 (01/05/2011)
3. • Article de périodique

   • 

   Identification of a second major tumor-specific antigen recognized by CTLs on mouse mastocytoma P815

   Bilsborough, Janine[UCL] Van Pel, Aline[UCL] Uyttenhove, Catherine[UCL] Boon, Thierry[UCL] Van den Eynde, Benoît[UCL] (1999) Journal of Immunology — Vol. 162, no. 6, p. 3534-3540 (1999)
4. • Article de périodique

   • 

   The capture proteasome assay (CAPA): a method to measure proteasome activity in vitro

   Vigneron, Nathalie[UCL] Abi Habib, Joanna[UCL] Van den Eynde, Benoît[UCL] (2015) Analytical Biochemistry — (22/04/2015)
5. • Communication

   • 

   Invited lecture: Tumor immune resistance based on tryptophan degradation by IDO

   Van den Eynde, Benoît[UCL] (2006) Dutch Tumor Immunology Meeting — Breukelen, The Netherlands
6. • Communication

   • 

   Invited Lecture: Alternative tumour antigens and the tumour proteasome

   Van den Eynde, Benoît[UCL] (2014) ESMO Symposium on Immuno-Oncology — Genève (Switzerland)
7. • Communication

   • 

   Restoring immune control of cancer using small molecule inhibitors of tryptophan catabolism

   Van den Eynde, Benoît[UCL] (2016) Oxford Chemical Immunology Conference — Oxford, England
8. • Communication

   • 

   Targeting IDO and TDO with small molecules to improve cancer immunotherapy

   Van den Eynde, Benoît[UCL] (2017) Medicinal Chemistry Spring Symposium 2017 — Utrecht, The Netherlands
9. • Communication

   • 

   Invited lecture: Genes coding for tumor antigens recognized by T cells

   Van den Eynde, Benoît[UCL] (1993) Cancer Vaccine Symposium — Emeryville-San Francisco, USA
10. • Communication

    • 

    Invited Lecture: Tumoral immune resistance resulting from constitutive expression of indoleamine 2,3-dioxygenase by tumor cells

    Van den Eynde, Benoît[UCL] (2007) 1st European IDO Meeting. Andreas Hermes Akademie — Bonn, Germany
11. • Communication

    • 

    Differential processing of tumor antigens by standard proteasome and the immunoproteasome

    Morel, Sandra[UCL] Chapiro, Jacques[UCL] Levy, F. Schiltz, O. Monsarrat, B. Claverol, B. Gairin, J.-E. Van den Eynde, Benoît[UCL] (2001) 4th Workshop on Proteasomes — Clermont-Ferrand, France
12. • Communication

    • 

    A single nucleotide polymorphism in the IL-12 receptor beta1 gene is associated with disease susceptibility in human SLE patients

    Lauwerys, Bernard[UCL] Van den Eynde, Benoît[UCL] Houssiau, Frédéric[UCL] (2005) Annual European Congress of Rheumatology — Vienna(Austria)
13. • Communication

    • 

    Invited lecture: Antigens recognized by T lymphocytes on kidney cancer

    Van den Eynde, Benoît[UCL] (1999) The European Cancer Conference 10 (ECCO 10) — Vienna, Austria
14. • Communication

    • 

    Invited lecture: Tumour antigens recognized by autologous cytolytic T lymphocytes

    Van den Eynde, Benoît[UCL] (1996) 2nd Institut Curie Medical Oncology Conference, Control and manipulation of malignant tumour spread — Institut Curie, Paris, France
15. • Article de périodique

    • 

    Tryptophan-degrading enzymes in tumoral immune resistance

    van Baren, Nicolas[UCL] Van den Eynde, Benoît[UCL] (2015) Frontiers in Immunology — Vol. 6, no. 34, p. 1-9 (03/02/2015)
16. • Communication

    • 

    Differential synovial expression of type I interferon-induced proteins and proteins involved in extracellular matrix repulation in SLE versus RA and OA arthritis.

    Nzeusseu-Toukap, Adrien Galant, Christine[UCL] Houssiau, Frédéric[UCL] Lauwerys, Bernard[UCL] Lories, Rik Van den Eynde, Benoît[UCL] (2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Washington (Dc)
17. • Article de périodique

    • 

    Minimal tolerance to a tumor antigen encoded by a cancer-germline gene

    Huijbers, Ivo[UCL] Soudja, Saïdi M. Uyttenhove, Catherine[UCL] Buferne, Michel Inderberg-Suso, Else-Marit Colau, Didier[UCL] Pilotte, Luc[UCL] Powis de Tenbossche, Céline[UCL] Chomez, Patrick[UCL] Brasseur, Francis[UCL] Schmitt-Verhulst, Anne-Marie Van den Eynde, Benoît[UCL] (2012) Journal of Immunology — Vol. 188, no. 1, p. 111-121 (01/01/2012)
18. • Communication

    • 

    Invited Lecture: Apoptosis of tumor-infiltrating T lymphocytes as a major mechanism of tumoral immune resistance in an autochthonous melanoma model

    Van den Eynde, Benoît[UCL] (2014) Invited Lecture — GSK Biologicals, Rixensart (Belgium)
19. • Communication

    • 

    Invited lecture: An antigenic peptide produced by peptide splicing by the proteasome

    Van den Eynde, Benoît[UCL] (2004) One-day Symposium “Advances in cancer immunotherapy”, Wessex Immunology Group — Southampton General Hospital, Southampton, England
20. • Communication

    • 

    Vacuolar pathway of long-peptide cross-presentation : paradoxical effect of TAP inhibition on HLA-A1-restricted cross-presentation

    Van den Eynde, Benoît[UCL] (2017) 9th International Workshop on Antigen Processing and Presentation — Salamanca, Spain
21. • Article de périodique

    • 

    DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells

    Rosinski, Kellie V. Fujii, Nobuharu Mito, Jeffrey K. Koo, Kevin K. W. Xuereb, Suzanne M. Sala-Torra, Olga Gibbs, James S. Radich, Jerald P. Akatsuka, Yoshiki Van den Eynde, Benoît[UCL] Riddell, Stanley R. Warren, Edus H. (2008) Blood — Vol. 111, no. 9, p. 4817-4826 (2008)
22. • Communication

    • 

    Invited lecture: Vaccin et thérapie génique: du rêve à la réalité

    Van den Eynde, Benoît[UCL] (1999) Symposium at the Faculté de Médecine, "New diagnostic and treatment perspectives in Prostate Cancer" — Université catholique de Louvain, Louvain-en-Woluwe, Belgium
23. • Communication

    • 

    Invited lecture: Tumor antigens and preclinical models for cancer immunotherapy

    Van den Eynde, Benoît[UCL] (2009) International Melanoma Workshop — Oxford, England
24. • Communication

    • 

    Tryptophane/kynurénines et tolérance immune

    Van den Eynde, Benoît[UCL] (2017) Les Journées Francophones de Nutrition 2017 — Nantes, France
25. • Communication

    • 

    Invited lecture: Identification of tumor antigens recognized by autologous CTL on human renal cell carcinoma

    Van den Eynde, Benoît[UCL] (1996) Renal cell carcinoma: recent progress and future directions, A comprehensive symposium of the National Cancer Institute (NCI) — Washington, USA

Pages